People In Brief
This article was originally published in The Gray Sheet
Executive Summary
D.C. consulting hire: Becker & Associates taps Elaine C. Messa as director, medical device quality systems and compliance. As former director of FDA's Los Angeles field district office, Messa oversaw the largest import operations and medical device workload in the agency, the health care consulting firm says. Messa, who has also chaired CDRH's field committee, left FDA in 1999 to join Quintiles Transnational. At Becker, Messa is charged with expanding the firm's compliance practice, where she will focus on enforcement action responses and international supply-chain risk management
You may also be interested in...
Acquisitions In Brief
Invitrogen deal for Applied Biosystems valued at $6.7 billion: Applera sells its Applied Biosystems research instrument business to biotech research firm Invitrogen for cash and stock worth $6.7 billion, creating "a global leader in biotechnology reagents and systems," the firms announce June 12. Invitrogen will pay $38 per share for Applied Biosystems - a 17% premium over the firm's June 11 closing price. Applera notes that the transaction, expected to close this fall, will have minimal impact on the timing of its previously planned spin-off of its smaller Celera Group diagnostics business, which is scheduled for July (1"The Gray Sheet" May 12, 2008, In Brief)
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.